Validation of rapid and simple LC–MS/MS method for determination of voriconazole in rat plasma
- 15 August 2007
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 44 (4), 985-990
- https://doi.org/10.1016/j.jpba.2007.03.026
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical pharmacokinetics of voriconazoleInternational Journal of Antimicrobial Agents, 2006
- Pharmacokinetic/Pharmacodynamic Profile of VoriconazoleClinical Pharmacokinetics, 2006
- Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose AdministrationAntimicrobial Agents and Chemotherapy, 2004
- Pharmacodynamics of a New Triazole, Posaconazole, in a Murine Model of Disseminated CandidiasisAntimicrobial Agents and Chemotherapy, 2004
- In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis ModelAntimicrobial Agents and Chemotherapy, 2003
- Antifúngicos de uso sistémicoEnfermedades Infecciosas y Microbiología Clínica, 2003
- THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMANDrug Metabolism and Disposition, 2003
- In Vivo Pharmacodynamics of a New Triazole, Ravuconazole, in a Murine Candidiasis ModelAntimicrobial Agents and Chemotherapy, 2003
- Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation RegimensAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Susceptibilities of Candida Bloodstream Isolates to the New Triazole Antifungal Agents BMS-207147, Sch 56592, and VoriconazoleAntimicrobial Agents and Chemotherapy, 1998